DaVita Inc. $DVA Shares Acquired by Nordea Investment Management AB

Nordea Investment Management AB increased its stake in DaVita Inc. (NYSE:DVA) by 18.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 338,192 shares of the company’s stock after purchasing an additional 51,607 shares during the quarter. Nordea Investment Management AB’s holdings in DaVita were worth $38,321,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. MAI Capital Management grew its position in DaVita by 23.4% during the second quarter. MAI Capital Management now owns 438 shares of the company’s stock worth $62,000 after buying an additional 83 shares during the period. NewEdge Advisors LLC lifted its position in shares of DaVita by 20.8% during the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after acquiring an additional 88 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of DaVita by 34.9% during the 3rd quarter. Smartleaf Asset Management LLC now owns 452 shares of the company’s stock valued at $59,000 after acquiring an additional 117 shares during the period. Bank of Nova Scotia boosted its stake in shares of DaVita by 2.5% during the 3rd quarter. Bank of Nova Scotia now owns 4,933 shares of the company’s stock worth $655,000 after acquiring an additional 120 shares in the last quarter. Finally, TD Private Client Wealth LLC grew its holdings in shares of DaVita by 30.9% in the 3rd quarter. TD Private Client Wealth LLC now owns 564 shares of the company’s stock worth $75,000 after acquiring an additional 133 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of DVA opened at $152.46 on Tuesday. DaVita Inc. has a fifty-two week low of $101.00 and a fifty-two week high of $159.42. The company has a market capitalization of $10.18 billion, a PE ratio of 15.38, a price-to-earnings-growth ratio of 0.52 and a beta of 0.94. The stock has a fifty day moving average of $136.31 and a two-hundred day moving average of $127.57.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Monday, February 2nd. The company reported $3.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.24 by $0.16. The business had revenue of $3.62 billion for the quarter, compared to analysts’ expectations of $3.51 billion. DaVita had a negative return on equity of 413.18% and a net margin of 5.47%.The business’s revenue was up 9.9% on a year-over-year basis. During the same quarter last year, the firm earned $2.24 earnings per share. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DVA. Barclays lifted their price objective on DaVita from $143.00 to $158.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 3rd. TD Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 3rd. Truist Financial set a $158.00 price target on DaVita in a research note on Thursday, February 5th. UBS Group boosted their price objective on shares of DaVita from $186.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of DaVita in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $155.80.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.